彩客化學(01986.HK)BPDA生產線預期完成時間推遲至今年底
彩客化學(01986.HK)公佈,其於河北彩客新材料科技股份建設的聯苯四甲酸二酐產品的生產線(BPDA生產線),由於今年初疫情復發,導致無法按計劃採購BPDA設備用於項目建設,故BPDA生產線的預期完成時間將推遲至今年底。
另外,BPDA生產線的建設將分爲兩期,第一期的目標是在今年底前完成產能爲每年300噸的生產線建設,並將在第一期生產線生產穩定並考慮市場狀況後開始第二期每年200噸產能的生產線建設。
集團BPDA產品總體產能規劃每年500噸保持不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.